|Bid||58.02 x 800|
|Ask||57.86 x 800|
|Day's Range||57.36 - 59.29|
|52 Week Range||41.82 - 88.00|
|Beta (5Y Monthly)||0.83|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for LIVN
LONDON, February 03, 2023--LivaNova launched SenTiva DUO™, an implantable pulse generator with a dual-pin header to provide VNS Therapy™ for drug-resistant epilepsy treatment.
LONDON, January 18, 2023--LivaNova PLC will host a conference call to discuss its fourth-quarter and full-year 2022 results on Feb. 22, 2023 at 1 p.m. London time (8 a.m. ET).
LONDON, December 13, 2022--LivaNova PLC today announced it received a close-out letter from the FDA for the Warning Letter the Company received on December 29, 2015.